MedTrace Logo

Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.

NCT06023706 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 188

Last updated 2026-02-24

No results posted yet for this study

Summary

The primary objective is to demonstrate the analgesic effect at day 60 of 8% capsaicin patch (Qutenza) for the treatment of patients with coccygodyinia.

Conditions

  • Coccyx Disorder
  • Neuropathic Pain
  • Coccygodynia

Interventions

DRUG

Capsaicin 179 Mg Cutaneous Patch

1 patch applied once for 1 hour

DRUG

Capsaicin low concentration patch (capsaicin 0,04%, 3,2 mg/cm2)

1 patch applied once for 1 hour

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-08
Primary Completion
2027-01-08
Completion
2027-06-08

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06023706 on ClinicalTrials.gov